Axe Compute (AGPU) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for November 25, 2025, with five key proposals for shareholder vote, including director elections, auditor ratification, equity plan amendment, warrant share issuance, and a say-on-pay advisory vote.
Shareholders of record as of October 24, 2025, are eligible to vote in person or by proxy, with detailed instructions provided for both record and beneficial owners.
Proxy solicitation is managed by Sodali & Co., with all costs borne by the company; directors and employees may also solicit proxies without additional compensation.
Voting matters and shareholder proposals
Election of two Class I directors for terms expiring at the 2028 Annual Meeting.
Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2025.
Approval of an amendment to the 2024 Equity Incentive Plan to increase authorized shares from 66,667 to 1,066,667 and set a 500,000 share cap for incentive stock options.
Approval of issuance of 14,903,393 shares of common stock upon exercise of pre-funded warrants, as required by Nasdaq rules.
Advisory vote on executive compensation (say-on-pay), with the board recommending approval.
Shareholder proposal and director nomination deadlines for the 2026 meeting are between August 27 and September 25, 2026.
Board of directors and corporate governance
Board consists of seven directors divided into three classes, with annual elections for one class; no term limits.
Recent changes include the resignation of Dr. Nancy Chung-Welch and appointment of Shawn Matthews.
Majority of directors are independent under Nasdaq standards; lead independent director role established.
Board committees include Audit, Compensation, Nominating and Governance, Merger & Acquisition, and a Cryptocurrency Subcommittee.
Board met nine times in 2024, with all directors attending at least 75% of meetings.
Latest events from Axe Compute
- Q2 2024 saw a $3.2M loss, cost cuts, and new AI/ML partnerships amid going concern risks.AGPU
Q2 20241 Feb 2026 - Registering 1.98M shares for resale; proceeds from warrant exercises fund operations.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology firm shifts capital to Aethir tokens, heightening volatility and regulatory risk.AGPU
Registration Filing16 Dec 2025 - AI oncology and ATH-focused treasury strategy drive growth amid high digital asset risk.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology and ATH-focused treasury strategy create high growth and risk exposure.AGPU
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify KPMG, and approve a new equity incentive plan.AGPU
Proxy Filing2 Dec 2025 - Proxy covers director elections, auditor, equity plan, warrant issuance, and executive pay votes.AGPU
Proxy Filing2 Dec 2025 - Votes sought for reverse split, $10M equity issuance, and adjournment to maintain Nasdaq listing.AGPU
Proxy Filing2 Dec 2025 - Vote on reverse split and new equity issuance to maintain Nasdaq listing and financial flexibility.AGPU
Proxy Filing2 Dec 2025